Bionano Genomics (BNGO) Net Income (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Net Income data on file, last reported at -$8.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income fell 167.67% year-over-year to -$8.3 million; the trailing twelve-month figure through Mar 2026 stood at -$5.1 million (up 93.88% YoY), and the FY2025 full-year result was $55000.0, up 100.05% from the prior year.
• Net Income slipped to -$8.3 million in Q1 2026, from $18.5 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $18.5 million in Q4 2025 to a low of -$112.6 million in Q3 2023.
• A 5-year average of -$28.6 million and a median of -$31.4 million in 2024 frame the typical range for Net Income.
• Across the five-year window, Net Income tumbled 253.88% in 2023 and jumped 190.51% in 2025, its largest moves.
• Tracing BNGO's Net Income over 5 years: stood at -$38.7 million in 2022, then fell by 13.48% to -$43.9 million in 2023, then jumped by 53.39% to -$20.5 million in 2024, then jumped by 190.51% to $18.5 million in 2025, then sank by 144.84% to -$8.3 million in 2026.
• Business Quant data shows BNGO's Net Income at -$8.3 million in Q1 2026, $18.5 million in Q4 2025, and -$8.5 million in Q3 2025.